A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/17/2011	CN1933836B Heteroaryl piperidine glycine transporter inhibitors
08/17/2011	CN1923194B Cortex fraxini coumarin composition
08/17/2011	CN1913886B 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/17/2011	CN1910154B Quinoline derivatives for use as mycobacterial inhibitors
08/17/2011	CN1898232B Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
08/17/2011	CN1894236B Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/17/2011	CN1878766B Methods for synthesizing quinolinone compounds
08/17/2011	CN1829511B Use of telmisartan and amlodipine or Nifedipine in preparing medicine for increasing insulin sensitivity
08/17/2011	CN1822765B Delivery of compounds with rehydrated blood cells
08/17/2011	CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses
08/17/2011	CN102159712A Rna antagonists targeting gli2
08/17/2011	CN102159585A Platinum complex with antitumor activity
08/17/2011	CN102159582A Oxazolopyrimidines as edg-1 receptor agonists
08/17/2011	CN102159579A Tricyclic indole derivatives and methods of use thereof
08/17/2011	CN102159577A Imidazo[1,2-a]pyrimidine derivatives, method for preparation thereof, use thereof as medicaments, pharmaceutical compositions and met inhibitors
08/17/2011	CN102159576A Improved production method for adefovir dipivoxil
08/17/2011	CN102159575A 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
08/17/2011	CN102159574A Tri-cyclic pyrazolopyridine kinase inhibitors
08/17/2011	CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors
08/17/2011	CN102159572A Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
08/17/2011	CN102159571A Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, potent hcv inhibitor
08/17/2011	CN102159570A Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
08/17/2011	CN102159569A Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT
08/17/2011	CN102159568A 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
08/17/2011	CN102159567A Process for the preparation of esomeprazole magnesium in a stable form
08/17/2011	CN102159566A Pyridone and pyridazone analogues as gpr119 modulators
08/17/2011	CN102159565A Benzimidazole compound in crystal form and salt thereof
08/17/2011	CN102159563A Novel substituted sulfamide derivatives
08/17/2011	CN102159562A Chromene modulators of chemokine receptor activity
08/17/2011	CN102159561A Glycoside derivatives and uses thereof
08/17/2011	CN102159559A Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
08/17/2011	CN102159558A 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
08/17/2011	CN102159557A Piperazine d3 and 5-ht2a receptor modulators
08/17/2011	CN102159556A 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
08/17/2011	CN102159555A Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases
08/17/2011	CN102159554A Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
08/17/2011	CN102159553A Targeted nitroxide agents
08/17/2011	CN102159548A Amide compounds useful in therapy
08/17/2011	CN102159547A Heterocyclic carboxamide compounds
08/17/2011	CN102159546A Aminopyridine kinase inhibitors
08/17/2011	CN102159545A Small molecule leptin receptor modulators
08/17/2011	CN102159544A Pyridyl modulators of gamma-secretase
08/17/2011	CN102159543A Novel triazolo(4,3-a)pyridine derivatives, process for preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
08/17/2011	CN102159542A New compounds vii
08/17/2011	CN102159541A Anticancer oral formulation
08/17/2011	CN102159539A A new metformin glycinate salt for blood glucose control
08/17/2011	CN102159537A Organic compounds for applications in bacterial infections treatment
08/17/2011	CN102159535A Potassium ion channel modulators & uses thereof
08/17/2011	CN102159531A Cyclohexenyl modulators of chemokine receptor activity
08/17/2011	CN102159284A Pharmaceutical combination of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and antiepileptic
08/17/2011	CN102159253A Image-guided therapy of myocardial disease: composition, manufacturing and applications
08/17/2011	CN102159247A Drug carriers
08/17/2011	CN102159223A Treating or preventing rotavirus infection
08/17/2011	CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
08/17/2011	CN102159221A Anti-infective formulation and methods of use
08/17/2011	CN102159220A Thiolated chitosan gel
08/17/2011	CN102159219A Method of enhancing tgf-beta signalling
08/17/2011	CN102159218A New chitin low polymer composition for medical use
08/17/2011	CN102159216A Methods and materials for treatment of acne
08/17/2011	CN102159215A Treating various disorders using trkb agonists
08/17/2011	CN102159214A Inhibitors of bruton's tyrosine kinase for treatment of solid tumors
08/17/2011	CN102159213A 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
08/17/2011	CN102159212A Use of opioids or opioid mimetics for treatment of resistant cancer patients
08/17/2011	CN102159211A Compositions for treatment of fibrotic diseases or conditions
08/17/2011	CN102159210A Methods for treating cns disorders
08/17/2011	CN102159209A The treatment of hearing loss
08/17/2011	CN102159208A 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands
08/17/2011	CN102159207A Substituted pyrrolidine-2-carboxamides
08/17/2011	CN102159206A Glucoside derivatives and uses thereof as sglt inhibitors
08/17/2011	CN102159205A Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
08/17/2011	CN102159204A Stable liquid antibody formulation
08/17/2011	CN102159203A Activatiqn of histone deacetylase 1 (hdac1) protects against DNA damage and increases neuronal survival
08/17/2011	CN102159202A Methods of administering topical antifungal formulations for treatment of fungal infections
08/17/2011	CN102159201A 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
08/17/2011	CN102159200A Novel sulphur containing lipids for use as food supplement or as medicament
08/17/2011	CN102159199A Composition containing 4-o-methylhonokiol for treating or preventing amyloid-related diseases
08/17/2011	CN102159198A Topical treatment of skin infection
08/17/2011	CN102159197A Compositions and methods for treating osteoarthritis
08/17/2011	CN102159196A Pharmaceutical formulation for treating upper digestive tract
08/17/2011	CN102159193A Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
08/17/2011	CN102159191A Medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer and process for makeing same
08/17/2011	CN102159190A Oral formulations of chemotherapeutic agents
08/17/2011	CN102159184A Liquid pharmaceutical formulation containing paracetamol
08/17/2011	CN102159183A Anesthetic composition, formulation and method of use
08/17/2011	CN102159093A Reducing astringency in compositions containing phenolic compounds
08/17/2011	CN102159080A Enzyme inhibitors and the use thereof
08/17/2011	CN102159078A Compounds as kinase inhibitors
08/17/2011	CN102159077A Methods for treating neuropathic pain
08/17/2011	CN102153668A Anticancer Armillaria luteovirens polysaccharide and extraction process thereof
08/17/2011	CN102153666A Sipunculidae polysaccharide and preparation method thereof and application thereof to anti-fatigue function
08/17/2011	CN102153614A Method for preparing effective monomer of total alkaloid extract of holarrhena antidysenterica and application thereof
08/17/2011	CN102153613A Method for preparing prunellin and application
08/17/2011	CN102153610A Nitric oxide donor type bile acid derivatives as well as preparation methods and medicinal application thereof
08/17/2011	CN102153607A Water soluble camptothecin derivative and medicinal composition containing same
08/17/2011	CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
08/17/2011	CN102153577A 2-seleno-N-pyridine oxide-rare earth metal ion compound and preparation method and application thereof
08/17/2011	CN102153575A Dioxane-coordinated rare-earth coordination compound, and preparation method and application thereof
08/17/2011	CN102153564A Nitrogen-atom-containing arteannuin dimers, and preparation method and application thereof
08/17/2011	CN102153562A Spiro-oxindole compounds and their uses as therapeutic agents
08/17/2011	CN102153558A Derivative of multi-target antitumor inhibitor 2-aminopyrrole-triazine and synthesis method thereof

1 ... 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 ... 7860